For the quarter ended June 2025, Astrazeneca (AZN) reported revenue of $14.46 billion, up 11.7% over the same period last year. EPS came in at $1.09, compared to $0.99 in the year-ago quarter.The reported revenue represents a surprise of +3.04% over the Zacks Consensus Estimate of $14.03 billion. With the consensus EPS estimate being $1.09, the company has not delivered EPS surprise.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wa ...